[
  {
    "ts": null,
    "headline": "JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?",
    "summary": "Both JNJ and ABBV expect their sales and profits to improve in 2025.",
    "url": "https://finnhub.io/api/news?id=334d0accc28e0b489dd375599fb803597bcfcc8689c0be018d7691970fe9b693",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746534360,
      "headline": "JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?",
      "id": 134266275,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Both JNJ and ABBV expect their sales and profits to improve in 2025.",
      "url": "https://finnhub.io/api/news?id=334d0accc28e0b489dd375599fb803597bcfcc8689c0be018d7691970fe9b693"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie to Present at the Bank of America Securities Healthcare Conference",
    "summary": "AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025. Management will participate in a fireside chat at 12:00 p.m. Central time.",
    "url": "https://finnhub.io/api/news?id=5553db7d70a06025f934da28d6bdee88740b7c989f9a9edb12767dd2ccf95535",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746532800,
      "headline": "AbbVie to Present at the Bank of America Securities Healthcare Conference",
      "id": 134266307,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025. Management will participate in a fireside chat at 12:00 p.m. Central time.",
      "url": "https://finnhub.io/api/news?id=5553db7d70a06025f934da28d6bdee88740b7c989f9a9edb12767dd2ccf95535"
    }
  },
  {
    "ts": null,
    "headline": "Putnam Large Cap Value Fund Q1 2025 Commentary",
    "summary": "While broader US equity markets were challenged in the first quarter, value stocks posted a small gain. Read more here.",
    "url": "https://finnhub.io/api/news?id=34e77d43dbd7aacedabe43f6352510b48fe8175853b5e3f0a3aa984ff76a4267",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746530880,
      "headline": "Putnam Large Cap Value Fund Q1 2025 Commentary",
      "id": 134265993,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2210232423/image_2210232423.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "While broader US equity markets were challenged in the first quarter, value stocks posted a small gain. Read more here.",
      "url": "https://finnhub.io/api/news?id=34e77d43dbd7aacedabe43f6352510b48fe8175853b5e3f0a3aa984ff76a4267"
    }
  },
  {
    "ts": null,
    "headline": "ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations",
    "summary": "We recently published a list of ChatGPT Stock Advice: Top 12 Stock Recommendations. In this article, we will take a look at where AbbVie Inc. (NYSE:ABBV) stands against other top stock recommendations by ChatGPT. After a two-year surge of 53%, the stock market has been taken for a wild ride in 2025, driven by uncertainties […]",
    "url": "https://finnhub.io/api/news?id=ccbd649549b03af10712b111c5600f56e09cc1dadd6fa8f04e8979f0f44ebc01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746523606,
      "headline": "ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations",
      "id": 134266308,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently published a list of ChatGPT Stock Advice: Top 12 Stock Recommendations. In this article, we will take a look at where AbbVie Inc. (NYSE:ABBV) stands against other top stock recommendations by ChatGPT. After a two-year surge of 53%, the stock market has been taken for a wild ride in 2025, driven by uncertainties […]",
      "url": "https://finnhub.io/api/news?id=ccbd649549b03af10712b111c5600f56e09cc1dadd6fa8f04e8979f0f44ebc01"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : AbbVie Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 10",
    "summary": "Presenter SpeechTimothy Anderson All Right. Thanks for joining us for this next session. I'm Tim Anderson, the U.S. large cap pharma and biotech analyst at Bank of America. Very happy to have with...",
    "url": "https://finnhub.io/api/news?id=890405ba5fe3fa248f09d476b17cd5f5b437c3792795c41daf028db6fddf142d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746518400,
      "headline": "Transcript : AbbVie Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 10",
      "id": 134448340,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "Presenter SpeechTimothy Anderson All Right. Thanks for joining us for this next session. I'm Tim Anderson, the U.S. large cap pharma and biotech analyst at Bank of America. Very happy to have with...",
      "url": "https://finnhub.io/api/news?id=890405ba5fe3fa248f09d476b17cd5f5b437c3792795c41daf028db6fddf142d"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Large Cap Stock Fund Q1 2025 Commentary",
    "summary": "For Q1 2025, Fidelity Large Cap Stock Fund returned -2.29%, outpacing the -4.27% result of the benchmark, the S&P 500Â® index. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=c1ee3994bb67cf94c9661e79b5bb51913258a0a7771892134c695c92d2161135",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746517500,
      "headline": "Fidelity Large Cap Stock Fund Q1 2025 Commentary",
      "id": 134260955,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158301126/image_2158301126.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "For Q1 2025, Fidelity Large Cap Stock Fund returned -2.29%, outpacing the -4.27% result of the benchmark, the S&P 500Â® index. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=c1ee3994bb67cf94c9661e79b5bb51913258a0a7771892134c695c92d2161135"
    }
  },
  {
    "ts": null,
    "headline": "On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst",
    "summary": "Chief executives at the largest drugmakers in the world are confident tariffs and pricing measures won’t be a major problem. But they’re still poised for change.",
    "url": "https://finnhub.io/api/news?id=2bfc3ab8e0442fc27d0361634160303c66db6088da7d4759322eb67ebdf86825",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746515400,
      "headline": "On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst",
      "id": 134266310,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Chief executives at the largest drugmakers in the world are confident tariffs and pricing measures won’t be a major problem. But they’re still poised for change.",
      "url": "https://finnhub.io/api/news?id=2bfc3ab8e0442fc27d0361634160303c66db6088da7d4759322eb67ebdf86825"
    }
  },
  {
    "ts": null,
    "headline": "Trump Sets Pharma Tariffs Deadline. The Fallout for Eli Lilly, Pfizer, Other Drugmakers.",
    "summary": "Trump Sets Pharma Tariffs Deadline. The Fallout for Eli Lilly, Pfizer, Other Drugmakers.",
    "url": "https://finnhub.io/api/news?id=820bea0b0815c83a1049933dbc00771f59dcf87bd7ea85f7edd919f984c819ec",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746514740,
      "headline": "Trump Sets Pharma Tariffs Deadline. The Fallout for Eli Lilly, Pfizer, Other Drugmakers.",
      "id": 134261871,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "Trump Sets Pharma Tariffs Deadline. The Fallout for Eli Lilly, Pfizer, Other Drugmakers.",
      "url": "https://finnhub.io/api/news?id=820bea0b0815c83a1049933dbc00771f59dcf87bd7ea85f7edd919f984c819ec"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Equity-Income Fund Q1 2025 Review",
    "summary": "The fund seeks a yield for its shareholders that exceeds the yield on the securities comprising the S&P 500 index.",
    "url": "https://finnhub.io/api/news?id=660a1b39f13a0fb9f0ac8254422c5c83e90d36540e1fad6071f3c0a53515fd13",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746510900,
      "headline": "Fidelity Equity-Income Fund Q1 2025 Review",
      "id": 134259938,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1365758819/image_1365758819.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "The fund seeks a yield for its shareholders that exceeds the yield on the securities comprising the S&P 500 index.",
      "url": "https://finnhub.io/api/news?id=660a1b39f13a0fb9f0ac8254422c5c83e90d36540e1fad6071f3c0a53515fd13"
    }
  },
  {
    "ts": null,
    "headline": "Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit - ABBV",
    "summary": "NEW YORK, May 6, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=9061a6bff6a16c61d7c077a2fc45f3903062fbe7be34acb68079fe82b6dc1bf6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746510376,
      "headline": "Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit - ABBV",
      "id": 134259758,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "NEW YORK, May 6, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=9061a6bff6a16c61d7c077a2fc45f3903062fbe7be34acb68079fe82b6dc1bf6"
    }
  },
  {
    "ts": null,
    "headline": "1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar",
    "summary": "\"Too big to fail\" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.",
    "url": "https://finnhub.io/api/news?id=e0dcc9b570076c321d94fa5b72e964e6b042bf0a1e36afd550aebc7623ec2e1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746506210,
      "headline": "1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar",
      "id": 134266311,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "\"Too big to fail\" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.",
      "url": "https://finnhub.io/api/news?id=e0dcc9b570076c321d94fa5b72e964e6b042bf0a1e36afd550aebc7623ec2e1c"
    }
  }
]